Kovack Advisors, Inc. Bristol Myers Squibb CO Call Options Transaction History

Kovack Advisors, Inc.

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2019 Oct 31, 2019	SELL	$42.77 - $50.71 $213 - $253	-5 Reduced 62.5%	3 $2,000
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $178 - $197	4 Added 100.0%	8 $2,000
Q1 2019 May 03, 2019	BUY	$45.12 - $53.8 $135 - $161	3 Added 300.0%	4 $2,000
Q1 2015 Nov 13, 2018	SELL	N/A	-2 Reduced 66.67%	1 $1,000
Q4 2014 Nov 19, 2018	SELL	N/A	-6 Reduced 66.67%	3 $2,000
Q3 2014 Dec 04, 2018	SELL	N/A	-10 Reduced 52.63%	9 $2,000
Q2 2014 Dec 18, 2018	BUY	N/A	9 Added 90.0%	19 $1,000
Q1 2014 Jan 28, 2019	BUY	N/A	4 Added 66.67%	10 $2,000
Q4 2013 Mar 15, 2019	SELL	N/A	-19 Reduced 76.0%	6 $2,000
Q3 2013 Apr 09, 2019	BUY	N/A	25	25 $7,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Kovack Advisors, Inc. with notifications on news.